-+ 0.00%
-+ 0.00%
-+ 0.00%

Did High NA Orders Just Shift ASML's (ENXTAM:ASML) Investment Narrative?

Simply Wall St·09/18/2026 09:18:09
Listen to the news
  • Samsung, TSMC, Intel and others have committed to ASML Holding’s High NA EUV systems, while ASML prepares major EUV capacity expansion supported by new alliances across quantum, memory and foundry customers.
  • The same High NA tools underpin both AI chip production and Xanadu’s photonic quantum hardware work. As a result, one product platform now straddles two compute frontiers with very different performance demands.
  • Next, the focus shifts to how ASML Holding’s investment narrative could be reshaped by rising High NA demand and constrained factory throughput.

Scan beyond ASML Holding and explore the same AI and quantum manufacturing wave with a hand picked list of 89 AI infrastructure stocks that are helping to power tomorrow's compute build out.

ASML Holding Investment Narrative Recap

To own ASML Holding, you need to believe that EUV and High NA platforms remain central to advanced chip production and that customers keep committing capital to these tools despite high upfront costs and long build cycles. The near term story is about execution, turning today’s near sold out capacity into actual shipments while managing supplier constraints.

The most important short term catalyst is ASML’s ability to ramp EUV output toward the more than 110 systems targeted for 2028, without bottlenecks in its new flow factory model. The biggest risk remains timing; if High NA adoption or broader semiconductor spending slows, order patterns and factory utilization could become less predictable.

The Xanadu collaboration is the announcement that most directly widens the High NA story. It pushes ASML Holding into photonic quantum hardware process work, where line edge roughness and optical loss become new performance levers on the same tool platform that serves AI logic and memory customers.

For you as a shareholder, this adds an extra optionality layer to the existing EUV thesis rather than changing the main near term catalyst. Execution in the Brainport capacity build out and High NA production ramp still matters more to earnings, while the quantum work increases technical depth but does not yet change the principal risk around tool maturity and customer adoption timing.

ASML Holding's current analyst narrative points to forecast revenue of €65.7b and consensus earnings of €25.3b by 2029, built on projected 23.0% yearly revenue growth, compared with earnings of €10.6b today. This implies an earnings increase of about €14.7b over that period.

Uncover how ASML Holding's fair value indicates a 43% potential upside to its current price, which may not last much longer.

ENXTAM:ASML 1-Year Stock Price Chart
ENXTAM:ASML 1-Year Stock Price Chart

Exploring Other Perspectives

One alternate view on ASML Holding places significantly more emphasis on the High NA catalyst you just saw in the Samsung, TSMC, Intel and Xanadu news. The most optimistic analysts were already modeling about €81.1b of revenue and €32.2b of earnings by 2029. You can treat those as a ceiling case and explore how this fresh wave of alliances might influence both the bullish and cautious narratives from here.

Explore 26 other ASML Holding fair value estimates, including one that suggests as much as 76% upside from the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

Looking For More Ideas Beyond ASML Holding?

If the ASML Holding story has sharpened your thinking about where capital flows next in chips and infrastructure, it can help to cross check that view against a broader watchlist. The Simply Wall St Screener lets you filter for specific traits so you can quickly spot other businesses that might fit your return goals and risk tolerance.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.